What patients want and need to know about atrial brillation. J Multidisciplinary Healthcare. 2011;4:413-419. 478. Pandya EY, Bajorek B. Factors Affecting patients perception on, and adherence to, anticoagulant therapy: anticipating the role of direct oral anticoagulants. Patient. 2017;10(2):163-185. 479. Kirchhof P. The future of atrial brillation management: integrated care and strati ed therapy. Lancet. 2017;390(10105):1873-1887. 480. Hendriks JM, Crijns HJ, Tieleman RG, Vrijhoef HJ. The atrial brillation knowledge scale: development, validation and results. Int J Cardiol. 2013;168(2):1422-1428. 481. Desteghe L, Engelhard L, Raymaekers Z, et al. Knowledge gaps in patients with atrial brillation revealed by a new validated knowledge questionnaire. Int J Cardiol. 2016;223:906-914. 482. Heidbuchel H, Berti D, Campos M, et al. Implementation of non- vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients. Thrombosis Journal. 2015;13:22. 483. Bakhai A, Sandberg A, Mittendorf T, et al. Patient perspective on the management of atrial brillation in ve European countries. BMC Cardiovasc Dis. 2013;13:108.